AzTrials
AzTrials

Primary Dysmenorrhea (PD)NCT07237802

Online Pain Neuroscience Education for Women With Primary Dysmenorrhea

A study testing PNE online + lifestyle recommendations. and Lifestyle recommendations in people with Primary Dysmenorrhea (PD), run by Cardenal Herrera University at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Primary dysmenorrhea is a highly prevalent condition characterized by recurrent menstrual pain in the absence of identifiable pelvic pathology. It affects up to 95% of menstruating women and often interferes with quality of life. Read more about this study

Who is it for?
Ages 18 to 35 years, women only
Conditions the study is for
Primary Dysmenorrhea (PD)
What is being tested?
PNE online + lifestyle recommendations. and Lifestyle recommendations
Could I receive a placebo?
No, everyone receives an active treatment
How many people
82 participants
Where
1 siteSpain
Study dates
10 Oct 2025to 28 May 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Nulliparous women aged 18 to 35 years.
  • Clinical diagnosis of primary dysmenorrhea.
  • History of moderate to severe menstrual pain for at least six consecutive menstrual cycles.
  • Pain intensity score greater than 5 on a numerical rating scale (0-10).
  • No prior use of pain neuroscience education (PNE).
  • No history of pregnancy.

Who cannot join

  • History of lower abdominal surgery.
  • Presence of severe mental health disorders.
  • Current use of hormonal contraceptives.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Universidad CEU Cardenal Herrera

    Valencia, Valencia-valència, 46006

Other trials in Spain

About this study

Official title: Efficacy of an Online Pain Neuroscience Education Intervention in Women With Primary Dysmenorrhea: A Randomized Controlled Trial

Primary dysmenorrhea is a highly prevalent condition characterized by recurrent menstrual pain in the absence of identifiable pelvic pathology. It affects up to 95% of menstruating women and often interferes with quality of life. Pain neuroscience education (PNE) has shown positive effects in musculoskeletal conditions but has not yet been studied in women with primary dysmenorrhea. This study aims to evaluate the effect of an online PNE intervention combined with lifestyle recommendations, compared to lifestyle recommendations alone

Read the detailed description

This randomized controlled trial will compare an online pain neuroscience education (PNE) program plus lifestyle recommendations with lifestyle recommendations alone in women with primary dysmenorrhea. Participants will be randomized (1:1) to either the intervention group (4-week online PNE modules plus lifestyle recommendations) or the control group (lifestyle recommendations only). The program is based on Butler and Moseley's pain neuroscience principles, adapted to menstrual pain. Outcomes will be assessed at baseline and at 6 months. The primary outcome is pain intensity. Secondary outcomes include anxiety, depression, kinesiophobia and pain catastrophizing,

Being tested
PNE online + lifestyle recommendations., Lifestyle recommendations
Keywords
Pain, Dysmenorrhea, Kinesiophobia
Medical subject headings
Pain, Dysmenorrhea, Kinesiophobia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PNE online + lifestyle recommendations.Other

    Four-week online educational program with audiovisual modules on the neurobiology and biopsychosocial aspects of pain, adapted to women with primary dysmenorrhea. In addition, participants receive usual lifestyle recommendations, including general advice on healthy habits and self-management strategies commonly provided in clinical practice.

  • Lifestyle recommendationsOther

    Participants in this arm will receive online lifestyle recommendations for four weeks, including general advice on healthy habits and self-management strategies commonly provided in clinical practice for women with primary dysmenorrhea.

Study groups in NCT07237802
Study groupRoleWhat they receive
Online Pain Neuroscience Education (PNE)ExperimentalParticipants in this arm will receive an online pain neuroscience education (PNE) program plus usual lifestyle recommendations. The PNE intervention consists of four weekly audiovisual and written modules adapted to the context of primary dysmenorrhea, focusing on the neurobiology and biopsychosocial aspects of pain, with practical strategies to reduce maladaptive beliefs, kinesiophobia, and catastrophizing.
Receives: Other: PNE online + lifestyle recommendations.
Active ComparatorActive comparatorParticipants in this arm will receive the usual lifestyle recommendations for primary dysmenorrhea. These recommendations include general advice on healthy habits and self-management strategies typically provided in clinical practice.
Receives: Other: Lifestyle recommendations

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain intensity measured by the 11-point Numeric Rating Scale (NRS)

    Pain intensity will be assessed using the 11-point Numeric Rating Scale (NRS). Participants will rate their average menstrual pain intensity over the previous cycle, from 0 ("no pain") to 10 ("worst imaginable pain"). Higher scores indicate greater pain intensity.

    Measured: pre-intervention and 6 months post-intervention

Secondary outcomes (3)
  1. Anxiety and depression measured by the Hospital Anxiety and Depression Scale (HADS)

    The Hospital Anxiety and Depression Scale (HADS) has 14 items, with two subscales: HADS-Anxiety (7 items) and HADS-Depression (7 items). Each subscale ranges 0-21; higher scores indicate greater anxiety/depression.

    Measured: pre-intervention and 6 months post-intervention

  2. Kinesiophobia measured by the Tampa Scale for Kinesiophobia-11 (TSK-11)

    The Tampa Scale for Kinesiophobia-11 (TSK-11) has 11 items scored 1 ("strongly disagree") to 4 ("strongly agree"). Total score 11-44; higher scores indicate greater fear of movement/re-injury.

    Measured: pre-intervention and 6 months post-intervention

  3. Pain catastrophizing measured by the Pain Catastrophizing Scale (PCS)

    The Pain Catastrophizing Scale (PCS) includes 13 items scored 0 ("not at all") to 4 ("all the time"). Total score 0-52; higher scores indicate greater pain catastrophizing.

    Measured: pre-intervention and 6 months post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Nov 2025
  2. Study start10 Oct 2025
  3. Primary completion28 May 2026
  4. Study completion28 May 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Individually randomized, two-arm parallel trial (1:1) comparing an online pain neuroscience education (PNE) program plus lifestyle recommendations with lifestyle recommendations alone in women with primary dysmenorrhea. Randomization will be computer-generated and allocation concealed by an independent researcher. Outcomes will be assessed at baseline and at 6-month follow-up by blinded assessors/analysts. Intention-to-treat analysis will be applied.
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
82 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07237802
Sponsor's protocol ID
UNIVERSITYCARDENALHERRERA-100
Status last verified
Oct 2026
First submitted
1 Oct 2025
Last updated
30 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Soderman L, Edlund M, Marions L. Prevalence and impact of dysmenorrhea in Swedish adolescents. Acta Obstet Gynecol Scand. 2019 Feb;98(2):215-221. doi: 10.1111/aogs.13480. Epub 2018 Nov 6.

    PubMed 30312470
  • Butler DS, Moseley GL. Explain Pain. 2nd ed. Adelaide, South Australia: Noigroup Publications; 2013.

Questions about this trial

What is this clinical trial studying?

A study testing PNE online + lifestyle recommendations. and Lifestyle recommendations in people with Primary Dysmenorrhea (PD), run by Cardenal Herrera University at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain intensity measured by the 11-point Numeric Rating Scale (NRS) (time frame: pre-intervention and 6 months post-intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07237802, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in